Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$931000.0.

  • Outset Medical's Net Cash Flow fell 10102.62% to -$931000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$88.5 million, marking a year-over-year decrease of 25945.95%. This contributed to the annual value of -$88.5 million for FY2025, which is 25945.95% down from last year.
  • Per Outset Medical's latest filing, its Net Cash Flow stood at -$931000.0 for Q4 2025, which was down 10102.62% from -$3.1 million recorded in Q3 2025.
  • Outset Medical's Net Cash Flow's 5-year high stood at $90.7 million during Q4 2024, with a 5-year trough of -$68.0 million in Q1 2022.
  • Over the past 5 years, Outset Medical's median Net Cash Flow value was -$16.1 million (recorded in 2022), while the average stood at -$14.5 million.
  • Within the past 5 years, the most significant YoY rise in Outset Medical's Net Cash Flow was 2831500.0% (2024), while the steepest drop was 492417.58% (2024).
  • Over the past 5 years, Outset Medical's Net Cash Flow (Quarter) stood at -$48.2 million in 2021, then surged by 57.11% to -$20.7 million in 2022, then skyrocketed by 255.95% to $32.2 million in 2023, then surged by 181.66% to $90.7 million in 2024, then plummeted by 101.03% to -$931000.0 in 2025.
  • Its Net Cash Flow stands at -$931000.0 for Q4 2025, versus -$3.1 million for Q3 2025 and -$36.4 million for Q2 2025.